Checkpoint Therapeutics, Inc. (CKPT) Financials
CKPT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 2.2 million | 21.3 million |
2023-06-30 | 8.3 million | 31.6 million |
2023-03-31 | 5.9 million | 28.1 million |
2022-12-31 | 13.3 million | 32.8 million |
CKPT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -14.8 million | 689000 |
2023-06-30 | -12.0 million | 567000 |
2023-03-31 | -14.0 million | 969000 |
2022-12-31 | -15.3 million | 639000 |
CKPT Net Income
No data available :(
CKPT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 1.8 million | - | - |
2023-06-30 | 7.4 million | - | - |
2023-03-31 | 4.8 million | - | - |
2022-12-31 | 12.1 million | - | - |
CKPT Shares Outstanding
CKPT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 5.5 million | 2.2 million | - |
2023-06-30 | - | 13.9 million | 2.3 million | - |
2023-03-31 | - | 15.8 million | 2.3 million | - |
2022-12-31 | - | 14.2 million | 2.5 million | - |
CKPT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 31000 | - |
2023-06-30 | 31000 | 13.9 million |
2023-03-31 | 35000 | 15.8 million |
2022-12-31 | 74000 | 14.2 million |
CKPT
Price: $1.48
52 week price:
Earnings Per Share: -3.17 USD
P/E Ratio: -0.46
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 87100
Ebitda: -5.9 millionMarket Capitalization: 65.3 million